Epileptic encephalopathy with global cerebral demyelination

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:353217OMIM:612949E88.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Epileptic encephalopathy with global cerebral demyelination is an extremely rare and severe neurological condition that affects the brain in two major ways. First, it causes epileptic encephalopathy, which means the brain experiences frequent and difficult-to-control seizures that interfere with normal brain development and function. Second, it involves global cerebral demyelination, meaning the protective covering (called myelin) around nerve fibers throughout the brain breaks down or fails to form properly. Myelin acts like insulation on electrical wires, helping brain signals travel quickly and efficiently. When myelin is damaged, the brain cannot communicate properly, leading to serious problems with movement, thinking, and development. Children with this condition typically present very early in life with seizures that are resistant to standard anti-seizure medications. They also show significant developmental delays or regression, meaning they may lose skills they had previously gained. Brain MRI scans reveal widespread loss of the white matter (myelin) in the brain. The condition is classified under metabolic disorders (ICD-10 code E88.8), suggesting an underlying metabolic or biochemical cause that disrupts both brain electrical activity and myelin maintenance. The treatment landscape for this condition is currently very limited. Management focuses primarily on controlling seizures as much as possible with anti-epileptic medications and providing supportive care including physical therapy, nutritional support, and management of complications. There is no cure or disease-modifying treatment available at this time, and the prognosis is generally poor.

Also known as:

Key symptoms:

Severe seizures that are hard to control with medicationDevelopmental delay or loss of previously learned skillsMuscle stiffness or spasticityWeak muscle tone (floppiness) in early infancyDifficulty feeding or swallowingPoor head controlVision problems or lack of visual trackingIntellectual disabilityFailure to reach developmental milestones like sitting or walkingAbnormal movements or posturingIrritability or excessive cryingBreathing difficultiesReduced responsiveness or alertness

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Aug 2020Vosoritide for Selected Genetic Causes of Short Stature

Andrew Dauber — PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Epileptic encephalopathy with global cerebral demyelination.

View clinical trials →

No actively recruiting trials found for Epileptic encephalopathy with global cerebral demyelination at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Epileptic encephalopathy with global cerebral demyelination community →

No specialists are currently listed for Epileptic encephalopathy with global cerebral demyelination.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Epileptic encephalopathy with global cerebral demyelination.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Epileptic encephalopathy with global cerebral demyelinationForum →

No community posts yet. Be the first to share your experience with Epileptic encephalopathy with global cerebral demyelination.

Start the conversation →

Latest news about Epileptic encephalopathy with global cerebral demyelination

No recent news articles for Epileptic encephalopathy with global cerebral demyelination.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the specific genetic cause of my child's condition, and has genetic testing been completed?,What seizure medications are we going to try, and what are the possible side effects?,Should we consider a ketogenic diet for seizure control?,What therapies (physical, occupational, speech) should my child be receiving, and how often?,What is the expected course of this condition, and how should we plan for the future?,Are there any clinical trials or research studies that my child might be eligible for?,Should we involve a palliative care team, and what support services are available for our family?

Common questions about Epileptic encephalopathy with global cerebral demyelination

What is Epileptic encephalopathy with global cerebral demyelination?

Epileptic encephalopathy with global cerebral demyelination is an extremely rare and severe neurological condition that affects the brain in two major ways. First, it causes epileptic encephalopathy, which means the brain experiences frequent and difficult-to-control seizures that interfere with normal brain development and function. Second, it involves global cerebral demyelination, meaning the protective covering (called myelin) around nerve fibers throughout the brain breaks down or fails to form properly. Myelin acts like insulation on electrical wires, helping brain signals travel quickly

How is Epileptic encephalopathy with global cerebral demyelination inherited?

Epileptic encephalopathy with global cerebral demyelination follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Epileptic encephalopathy with global cerebral demyelination typically begin?

Typical onset of Epileptic encephalopathy with global cerebral demyelination is neonatal. Age of onset can vary across affected individuals.